ANAYLISIS OF NOVEL PROSTATE CANCER BIOMARKERS AND THEIR PREDICTIVE UTILITY IN AN ACTIVE SURVEILLANCE PROTOCAOL

$1,404,000FY2011Department of DefenseDOD

The General Hospital Corporation

Investigators